As I said, Mr. Cumming, if you look at the portfolio of vaccines that we have to date, these discussions were for a very brief moment. After that, we moved on. We selected the pillars, I would say, that will be the pillars of our resilience here in Canada when it comes to biomanufacturing.
You talk about Medicago. You talk about VIDO. You talk about AbCellera in Vancouver and now Novavax. My point is that, following that, we selected, with Minister Anand, seven vaccine candidates around the world. Two of them—the Pfizer and the Moderna—have been approved by Health Canada. That's the rollout that we have in Canada.
The episode you're talking about was just one of the different vaccine candidates that were looked at, at a very early stage, and then we moved on quickly. Today, we have the largest portfolio of vaccines to provide for and, obviously, to protect the health and safety of Canadians.